Patent · US Active

Glycemic risk determination based on variability of glucose levels

US9351670B2 · kind B2 · utility

19Cited by

71References

24Claims

0Family size

Assignee

ABBOTT DIABETES CARE INC. · US

Inventors

Timothy C. Dunn · San Francisco, US
Kenneth J. Doniger · Menlo Park, US
Glenn Berman · Alameda, US
Gary Alan Hayter · Oakland, US
Erwin Satrya Budiman · Fremont, US
Daniel M. Bernstein · El Granada, US
Nathan Crouther · San Francisco, US

Key dates

Filing date	Dec 31, 2012
Grant date	May 31, 2016
Priority date	—
Expiry date	Apr 28, 2034

Classification

Technology area (CPC G)Physics
CPC primaryG16Z99/00
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

A system and method for determining glycemic risks based on an analysis of glucose data includes visualization of hypoglycemia, variability, and hyperglycemia with a control grid, increasing the accuracy of glucose estimates using a combination of CGM and HbA1c, calculating glycemic risk by applying a probability distribution, and tailoring SMBG test schedules based on CGM use/wear.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.